Skip to main content
Top
Published in: Globalization and Health 1/2006

Open Access 01-12-2006 | Research

Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States

Authors: Ruifang Zhang, Karen Eggleston, Vincent Rotimi, Richard J Zeckhauser

Published in: Globalization and Health | Issue 1/2006

Login to get access

Abstract

Background

Antimicrobial resistance is an under-appreciated threat to public health in nations around the globe. With globalization booming, it is important to understand international patterns of resistance. If countries already experience similar patterns of resistance, it may be too late to worry about international spread. If large countries or groups of countries that are likely to leap ahead in their integration with the rest of the world – China being the standout case – have high and distinctive patterns of resistance, then a coordinated response could substantially help to control the spread of resistance. The literature to date provides only limited evidence on these issues.

Methods

We study the recent patterns of antibiotic resistance in three geographically separated, and culturally and economically distinct countries – China, Kuwait and the United States – to gauge the range and depth of this global health threat, and its potential for growth as globalization expands. Our primary measures are the prevalence of resistance of specific bacteria to specific antibiotics. We also propose and illustrate methods for aggregating specific "bug-drug" data. We use these aggregate measures to summarize the resistance pattern for each country and to study the extent of correlation between countries' patterns of drug resistance.

Results

We find that China has the highest level of antibiotic resistance, followed by Kuwait and the U.S. In a study of resistance patterns of several most common bacteria in China in 1999 and 2001, the mean prevalence of resistance among hospital-acquired infections was as high as 41% (with a range from 23% to 77%) and that among community- acquired infections was 26% (with a range from 15% to 39%). China also has the most rapid growth rate of resistance (22% average growth in a study spanning 1994 to 2000). Kuwait is second (17% average growth in a period from 1999 to 2003), and the U.S. the lowest (6% from 1999 to 2002). Patterns of resistance across the three countries are not highly correlated; the most correlated were China and Kuwait, followed by Kuwait and the U.S., and the least correlated pair was China and the U.S.

Conclusion

Antimicrobial resistance is a serious and growing problem in all three countries. To date, there is not strong international convergence in the countries' resistance patterns. This finding may change with the greater international travel that will accompany globalization. Future research on the determinants of drug resistance patterns, and their international convergence or divergence, should be a priority.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference Wilson KH, Blitchington RB: Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62(7):2273-2278. Wilson KH, Blitchington RB: Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62(7):2273-2278.
4.
go back to reference Institute of Medicine: Emerging infections: microbial threats to health in the United States. National Academy Press 1994. Institute of Medicine: Emerging infections: microbial threats to health in the United States. National Academy Press 1994.
5.
go back to reference Wilson KH, Blitchington RB: Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62(7):2273-8. Wilson KH, Blitchington RB: Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62(7):2273-8.
7.
go back to reference Field HJ, Coen DM: Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol 1986,60(1):286-289.PubMedPubMedCentral Field HJ, Coen DM: Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene. J Virol 1986,60(1):286-289.PubMedPubMedCentral
8.
go back to reference Muder RR, Brennen C, Wagener MM, et al.: Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993–1995) analysis. J Clin Microbiol 1996, 34: 2537-2543. Muder RR, Brennen C, Wagener MM, et al.: Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993–1995) analysis. J Clin Microbiol 1996, 34: 2537-2543.
9.
go back to reference Bisognano C, et al.: Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997,41(5):906-913.PubMedPubMedCentral Bisognano C, et al.: Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997,41(5):906-913.PubMedPubMedCentral
10.
go back to reference World Health Organization: WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva 2001. World Health Organization: WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva 2001.
11.
go back to reference Arason VA, Kristinsson KG, et al.: Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996, 313: 387-91.CrossRefPubMedPubMedCentral Arason VA, Kristinsson KG, et al.: Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 1996, 313: 387-91.CrossRefPubMedPubMedCentral
12.
go back to reference Seppala H, Klaukka T, et al.: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997, 337: 441-6. 10.1056/NEJM199708143370701CrossRefPubMed Seppala H, Klaukka T, et al.: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997, 337: 441-6. 10.1056/NEJM199708143370701CrossRefPubMed
13.
go back to reference Levy SB, Fitzgerald GB, Macone AB: Spread of Antibiotic-Resistant Plasmids from Chicken to Chicken and from Chicken to Man. Nature 1976,260(5546):40-42. 10.1038/260040a0CrossRefPubMed Levy SB, Fitzgerald GB, Macone AB: Spread of Antibiotic-Resistant Plasmids from Chicken to Chicken and from Chicken to Man. Nature 1976,260(5546):40-42. 10.1038/260040a0CrossRefPubMed
14.
go back to reference Levy SB, Fitzgerald GB, Macone AB: Changes in Intestinal Flora of Farm Personnel after Introduction of a Tetracycline-Supplemented Feed on a Farm. N Engl J Med 1976, 295: 583-588.CrossRefPubMed Levy SB, Fitzgerald GB, Macone AB: Changes in Intestinal Flora of Farm Personnel after Introduction of a Tetracycline-Supplemented Feed on a Farm. N Engl J Med 1976, 295: 583-588.CrossRefPubMed
15.
go back to reference Witte W: Selective pressure by antibiotic use in livestock. Int J Antimicrob Agents 2000,16(Suppl 1):S19-24. ReviewCrossRefPubMed Witte W: Selective pressure by antibiotic use in livestock. Int J Antimicrob Agents 2000,16(Suppl 1):S19-24. ReviewCrossRefPubMed
16.
go back to reference Breathnach AS, de Ruiter A, Holdsworth GM, et al.: An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect 1998,39(2):111-117. 10.1016/S0195-6701(98)90324-3CrossRefPubMed Breathnach AS, de Ruiter A, Holdsworth GM, et al.: An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect 1998,39(2):111-117. 10.1016/S0195-6701(98)90324-3CrossRefPubMed
17.
go back to reference Hannan MM, Azadian BS, Gazzard BG, et al.: Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis. J Hosp Infect 2000,44(1):5-11. 10.1053/jhin.1999.0651CrossRefPubMed Hannan MM, Azadian BS, Gazzard BG, et al.: Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis. J Hosp Infect 2000,44(1):5-11. 10.1053/jhin.1999.0651CrossRefPubMed
18.
go back to reference Martin MA: Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis 1994, 14: 170-191.PubMed Martin MA: Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis 1994, 14: 170-191.PubMed
19.
go back to reference Wang F, Zhu D, et al.: Surveillance of bacterial resistance in Shanghai. Chin J Infect Chemother 2002,2(1):1-9. Wang F, Zhu D, et al.: Surveillance of bacterial resistance in Shanghai. Chin J Infect Chemother 2002,2(1):1-9.
20.
go back to reference Cox RA, Conquest C, Malaghan C, et al.: A major outbreak of methicillin-resistant Staphylococcus aureus caused by new phage-type (EMRSA-16). J Hosp Infect 1995, 29: 87-106. 10.1016/0195-6701(95)90191-4CrossRefPubMed Cox RA, Conquest C, Malaghan C, et al.: A major outbreak of methicillin-resistant Staphylococcus aureus caused by new phage-type (EMRSA-16). J Hosp Infect 1995, 29: 87-106. 10.1016/0195-6701(95)90191-4CrossRefPubMed
21.
go back to reference Astagneau P, et al.: Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. J Hosp Infect 1999, 42: 303-312. 10.1053/jhin.1998.0612CrossRefPubMed Astagneau P, et al.: Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. J Hosp Infect 1999, 42: 303-312. 10.1053/jhin.1998.0612CrossRefPubMed
22.
go back to reference Haley RW, Morgan WM, Culver DH, et al.: Update from the SENIC project. Hospital infection control: Recent progress and opportunities under prospective payment. Am J Infect Control 1985, 13: 97-108. 10.1016/0196-6553(85)90085-9CrossRefPubMed Haley RW, Morgan WM, Culver DH, et al.: Update from the SENIC project. Hospital infection control: Recent progress and opportunities under prospective payment. Am J Infect Control 1985, 13: 97-108. 10.1016/0196-6553(85)90085-9CrossRefPubMed
23.
24.
go back to reference Tsiodras S, Gold H, et al.: Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358: 207-208. 10.1016/S0140-6736(01)05410-1CrossRefPubMed Tsiodras S, Gold H, et al.: Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358: 207-208. 10.1016/S0140-6736(01)05410-1CrossRefPubMed
25.
go back to reference Chen H, Ma Y, National Antimicrobial Resistance Surveillance Center, et al.: The Changing Patterns of Ciprofloxacin Resistant Bacteria Strains Isolated from Fifty Hospitals in China from 1994 to 2000. Chin J Infect Chemotherapy 2002,2(4):43-45. Chen H, Ma Y, National Antimicrobial Resistance Surveillance Center, et al.: The Changing Patterns of Ciprofloxacin Resistant Bacteria Strains Isolated from Fifty Hospitals in China from 1994 to 2000. Chin J Infect Chemotherapy 2002,2(4):43-45.
26.
go back to reference Li J, Li G, Wang J: Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. Natl Med J China 2003,83(5):365-374. (in Chinese) Li J, Li G, Wang J: Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. Natl Med J China 2003,83(5):365-374. (in Chinese)
27.
go back to reference Li J, Li G, Wang J: Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. Natl Med J China 2003,83(12):1035-1045. (in Chinese) Li J, Li G, Wang J: Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections. Natl Med J China 2003,83(12):1035-1045. (in Chinese)
31.
go back to reference Eggleston KE, Rotimi V, Ghayda A, Zhang R, Zeckhauser RJ: An economic analysis of antimicrobial resistance in Kuwait. J Antimicrobial Chemotherapy Forthcoming Eggleston KE, Rotimi V, Ghayda A, Zhang R, Zeckhauser RJ: An economic analysis of antimicrobial resistance in Kuwait. J Antimicrobial Chemotherapy Forthcoming
32.
go back to reference Neuhauser MM: Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003,289(7):885-888. 10.1001/jama.289.7.885CrossRefPubMed Neuhauser MM: Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003,289(7):885-888. 10.1001/jama.289.7.885CrossRefPubMed
33.
go back to reference Sun Z: Antimicrobial resistance and clinical interventions. Adverse Drug Reaction J 2003, 3: 151-155. Sun Z: Antimicrobial resistance and clinical interventions. Adverse Drug Reaction J 2003, 3: 151-155.
34.
go back to reference McDonald LC, Lauderdale T, et al.: The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme 2000. Int J Antimicrob Agents 2004,23(4):362-370. 10.1016/j.ijantimicag.2003.09.021CrossRefPubMed McDonald LC, Lauderdale T, et al.: The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme 2000. Int J Antimicrob Agents 2004,23(4):362-370. 10.1016/j.ijantimicag.2003.09.021CrossRefPubMed
Metadata
Title
Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States
Authors
Ruifang Zhang
Karen Eggleston
Vincent Rotimi
Richard J Zeckhauser
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2006
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/1744-8603-2-6

Other articles of this Issue 1/2006

Globalization and Health 1/2006 Go to the issue